Blueprint Medicines Corp (19)
Browse by Contract Category
Contracts
-
Amended and Restated Employment Agreement, dated January 11, 2021, by and between the Registrant and Becker Hewes, M.D
(Filed With SEC on January 11, 2021)
-
Sales Agreement, dated as of July 30, 2020, by and between Blueprint Medicines Corporation and Cowen and Company, LLC
(Filed With SEC on July 31, 2020)
-
2015 Employee Stock Purchase Plan
(Filed With SEC on February 13, 2020)
-
Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended
(Filed With SEC on February 13, 2020)
-
License Agreement, effective October 15, 2019, by and between Blueprint Medicines Corporation and Clementia Pharmaceuticals, Inc
(Filed With SEC on November 5, 2019)
-
First Amendment to Employment Agreement, dated January 11, 2021, by and between Blueprint Medicines Corporation and Anthony L. Boral, M.D., Ph.D
(Filed With SEC on January 11, 2021)
-
Employment Agreement, effective September 1, 2020, by and between Blueprint Medicines Corporation and Fouad Namouni, M.D
(Filed With SEC on September 1, 2020)
-
Eighth Amendment to Collaboration and License Agreement, effective April 30, 2020, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines Corporation
(Filed With SEC on May 6, 2020)
-
Employment Agreement, dated November 22, 2017, by and between the Registrant and Debra Durso-Bumpus, as amended by the First Amendment to Employment Agreement, dated February 10,...
(Filed With SEC on February 13, 2020)
-
2015 Stock Option and Incentive Plan and forms of award agreements thereunder
(Filed With SEC on February 13, 2020)
-
Underwriting Agreement, dated as of January 22, 2020, among Blueprint Medicines Corporation and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the...
(Filed With SEC on January 23, 2020)
-
Seventh Amendment to Collaboration and License Agreement, effective December 17, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines...
(Filed With SEC on December 20, 2019)
-
Sixth Amendment to Collaboration and License Agreement, effective November 1, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines...
(Filed With SEC on November 5, 2019)
-
Fifth Amendment to Collaboration and License Agreement, effective June 28, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines Corporation
(Filed With SEC on July 3, 2019)
-
Underwriting Agreement, dated as of March 28, 2019, among Blueprint Medicines Corporation and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the...
(Filed With SEC on March 29, 2019)
-
Employment Agreement, effective March 6, 2019, by and between Blueprint Medicines Corporation and Ariel Hurley
(Filed With SEC on March 8, 2019)
-
Fourth Amendment to Collaboration and License Agreement, effective February 25, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and the Registrant
(Filed With SEC on February 26, 2019)
-
First Amendment to Employment Agreement, dated January 30, 2019, by and between the Registrant and Michael Landsittel
(Filed With SEC on February 5, 2019)
-
First Amendment to Employment Agreement, dated January 30, 2019, by and between the Registrant and Kathryn Haviland
(Filed With SEC on February 5, 2019)